Abstract
Çocuklarda akut tonsillofarenjitin en yaygın bakteriyel etkeni A grubu beta hemolitik streptokoktur. Eritrojenik ekzotoksinler üreten A grubu beta hemolitik streptokok suşları kızıl olarak bilinen tipik bir döküntülü hastalık oluşturur. Komplikasyonları iyi tanımlanmıştır. Hepatit nadir bir komplikasyonudur. Burada, 7 yaşında kızıl olan ve karaciğer enzimleri yükselmiş bir kız hasta sunulmuştur. Hepatite yol açan virüsler gösterilememiştir. Boğaz kültüründe A grubu beta hemolitik streptokok üremiştir. A grubu beta hemolitik streptokok enfeksiyonlarında hepatit gelişebileceği göz ardı edilmemelidir.
Keywords
References
- Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. J Paediatr Child Health 2007;43:203-13.
- Wong SSY, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerging Microbes & Infections 2012;1:e2;doi:10.1038/emi.2012.9 Published online 11 July 2012
- Gutiérrez Junquera C, Escudero Canto MC, Ruiz Cano R, Cuartero del Pozo I, Gil Pons E. Cholestatic hepatitis as initial manifestation of scarlet fever. An Pediatr (Barc) 2003;59:193–4.
- Gómez-Carrasco JA, Lassaletta A, Ruano D. Acute hepatitis may form part of scarlet fever. An Pediatr (Barc) 2004;60:382–3.
- Gidaris D, Zafeiriou D, Mavridis P, Gombakis N. Scarlet fever and hepatitis: A case report. Hippokratia 2008;12:186–7.
- Girisch M, Heininger U. Scarlet fever associated with hepatitis-A report of two cases. Infection 2000; 28:251–3.
- Elishkewitz K, Shapiro R, Amir J, Nussinovitch M. Hepatitis in scarlet fever. Isr Med Assoc J 2004;6:569-70.
- Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variations in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000;30:3247-55.
- Brody H, Smith LW. The visceral pathology in scarlet fever and the related Streptococcus infections. Amer J Path 1936;12:373- 394.5.
- Stevens DL. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-78.
- Mcmahon HE, Mallry FB. Streptococcus hepatitis. Am J Pathol 1931;7:299-325.
- Kocak N, Ozsoylu S, Ertugrul M, Ozdol G. Liver damage in scarlet fever. Descriptions of two affected children. Clin Pediatr (Phila) 1976;15:462-4.
- Robbens E, De Man M, Schurgers M, Boelaert J, Lameire N. Systemic complications of streptococcal scarlet fever: Two case reports and a review of the literature. Acta Clin Belg 1986;41: 311-8.
- Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post strep- tococcal reactive arthritis: A clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 1999;245:261-7.
- Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16:792-800.
Abstract
The most common cause of tonsillopharyngitis is group A beta hemolytic streptococcal infection in children. Group A beta hemolytic streptococcus strains that produce erythrogenic exotoxins cause a typical exanthematous disease called scarlet fever. Complications are well described. Hepatitis is a rare complication. We present a 7-year old girl with scarlet fever and elevated liver transaminases in this report. Viruses that lead to hepatitis were not demonstrated. Group A beta hemolytic streptococcus was isolated from the throat culture of the patient. Hepatitis should not be overlooked in patients with group A beta hemolytic streptococcal infections
Keywords
References
- Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. J Paediatr Child Health 2007;43:203-13.
- Wong SSY, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerging Microbes & Infections 2012;1:e2;doi:10.1038/emi.2012.9 Published online 11 July 2012
- Gutiérrez Junquera C, Escudero Canto MC, Ruiz Cano R, Cuartero del Pozo I, Gil Pons E. Cholestatic hepatitis as initial manifestation of scarlet fever. An Pediatr (Barc) 2003;59:193–4.
- Gómez-Carrasco JA, Lassaletta A, Ruano D. Acute hepatitis may form part of scarlet fever. An Pediatr (Barc) 2004;60:382–3.
- Gidaris D, Zafeiriou D, Mavridis P, Gombakis N. Scarlet fever and hepatitis: A case report. Hippokratia 2008;12:186–7.
- Girisch M, Heininger U. Scarlet fever associated with hepatitis-A report of two cases. Infection 2000; 28:251–3.
- Elishkewitz K, Shapiro R, Amir J, Nussinovitch M. Hepatitis in scarlet fever. Isr Med Assoc J 2004;6:569-70.
- Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variations in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000;30:3247-55.
- Brody H, Smith LW. The visceral pathology in scarlet fever and the related Streptococcus infections. Amer J Path 1936;12:373- 394.5.
- Stevens DL. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1:69-78.
- Mcmahon HE, Mallry FB. Streptococcus hepatitis. Am J Pathol 1931;7:299-325.
- Kocak N, Ozsoylu S, Ertugrul M, Ozdol G. Liver damage in scarlet fever. Descriptions of two affected children. Clin Pediatr (Phila) 1976;15:462-4.
- Robbens E, De Man M, Schurgers M, Boelaert J, Lameire N. Systemic complications of streptococcal scarlet fever: Two case reports and a review of the literature. Acta Clin Belg 1986;41: 311-8.
- Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post strep- tococcal reactive arthritis: A clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 1999;245:261-7.
- Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16:792-800.
Details
| Other ID | JA66YN47YP |
|---|---|
| Journal Section | Case Report |
| Authors | |
| Publication Date | June 1, 2015 |
| Submission Date | June 1, 2015 |
| Published in Issue | Year 2015 Volume: 9 Issue: 2 |
The publication language of Turkish Journal of Pediatric Disease is English.
Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.
The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.